Cite
HARVARD Citation
Ferrara, R. et al. (n.d.). 1416PImmunosenescence (iSenescence) correlates with disease progression in advanced non-small cell lung cancer (aNSCLC) patients treated with PD-(L)1 inhibitors (IO). Annals of oncology. p. . [Online].